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Conclusion: The MDC-OVER-UNDER analysis as an assessment 
tool, has the potential to reduce labour, reduce inter/intra 
observer variability and provide rapid quantified feedback. 
Consistently failing volumes would trigger protocol review in 
the first instance. Wider application in an RTTQA or 
educational setting requires a consensus min/max extent 
volume for several operator defined volumes by the TMG 
from the outset, supported by the STAPLE algorithm. 
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Purpose or Objective: The TRENDY trial is an international 
multi-center phase II study in which patients with 
hepatocellular carcinoma (HCC) are randomized between 
transarterial chemoembolization in the standard arm and 
stereotactic body radiation therapy (SBRT) in the 
experimental arm. SBRT is delivered in six fractions with a 
total target dose of 48-54 Gy. Since the treatment is 
technologically challenging, an extensive quality assurance 
(QA) program has been established. The main goal is to 
ensure high quality treatments in order to achieve an optimal 
clinical outcome. 
 
Material and Methods: QA guidelines and recommendations 
are outlined in a separate QA protocol, which also defines 
minor and major protocol deviations. Treatment is not 
allowed with a major deviation. If possible minor deviations 
must be avoided. Centers can only start entering patients 
with a successfully completed external dosimetry audit. Prior 
to patient inclusion, a QA questionnaire should be filled out 
with regards to imaging modalities, treatment planning, 
patient setup, margins, breathing-motion management and 
treatment delivery. Besides that, centers are requested to 
complete a dummy run, including contouring and treatment 
planning. Contours are evaluated by comparison with golden 
contours, based on consensus within an expert panel. 
Treatment plans are evaluated using the constraints and 
objectives outlined in the treatment protocol, including an 
NTCP for the healthy liver. During patient accrual, the QA 
protocol accommodates prospective feedback for the first 
patients from each center. 
 
Results: Ten participating institutes completed and 
submitted the dummy-run. All contours were considered 
acceptable, although variation in both liver and GTV contours 
was substantial as shown in the figure below. Both individual 
feedback and general recommendations regarding 
delineations have been provided. The results of the 
treatment planning round are summarized in the table below. 
Two centers (III and VII) did not meet the NTCP constraint 
initially and re-planned the dummy-run patient after 
feedback had been provided. Dose homogeneity and 
conformity vary substantially, with some institutes aiming at 
a high target dose allowing for large dose gradients in the 
GTV-PTV margin, and others optimizing for a smoother, more 
homogeneous, dose distribution. 
 
 
 
Above: Axial slices with liver (left) and GTV (right) contours 
of the participating institutes. Below: Protocol requirements 
and planning dummy-run results. Roman numbers (I, II, …) 
refer to the institutes and replannings are indicated with an 
asterisk (*). 
 
Conclusion: As part of the TRENDY randomized trial, an 
extensive QA program has been implemented including a 
dummy run. Individual feedback and general 
recommendations have been provided to the participating 
centers, and will continue to be provided while patients are 
included. 
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Purpose or Objective: To develop and assess methodologies 
necessary for baseline alignment and dosimetry 
measurements for a fixed horizontal radiation beam as may 
occur in heavy ion and proton facilities and is the case for 
the Australian MRI-linac program (AMP) 
 
Material and Methods: The AMP utilises a fixed horizontal 
beam which is parallel to the magnetic field. To maximise 
flexibility the entire linac system (a linatron and independent 
millennium MLC system, Varian Inc) can be moved on a rail 
